Syensqo Sa/nv · EURONEXT:SYENS

Syensqo Sa/nv — Q2 2024 Earnings Presentation

14 slides from Syensqo Sa/nv's earnings presentation, Aug 1, 2024

  1. Slide 1: Second Quarter 2024 Results

    Second Quarter 2024 Results August 1, 2024

  2. Slide 2: Second Quarter 2024 Results

    Second Quarter 2024 Results Dr. ILHAM KADRI Chief Executive Officer August 1, 2024 ■ Continued improvement in YoY volume momentum ■ Underlying EBITDA of €378 million in line with expectations - with strong cash conversion CHRISTOPHER DAVIS Chief Financial Officer ■ Full year 2024 outlook range narro

  3. Slide 3: 7 months old, 160 years wise

    7 months old 160 years wise ■ Up and running ■ Delivering on expectations ■ Winning investor’s confidence ■ Innovation at core with + 2.000 scientists ■ Serie of bolt-on acquisitions linked to bioeconomy ■ Many strong partnerships across sectors 3

  4. Slide 4: Second Quarter in line with expectations

    Second Quarter in line with expectations NET GROSS ■ Continued improvement in volume momentum SALES PROFIT ■ Underlying EBITDA in-line with expectations € 1.71bn € 582mn ■ Strong discipline on pricing and costs flat volumes 34.1% margin -5% pricing ■ 88% cash conversion[1] ■ Successfully completed i

  5. Slide 5: Second Quarter 2024 Segment Highlights

    Second Quarter 2024 Segment Highlights CONSUMER & RESOURCES ■ Improved volume momentum with 10% YoY MATERIALS growth ■ Balancing price/volume to maximise value ■ Strong YoY growth in Composite Materials; Aero and defense up double digits growth ■ Slower recovery in Agro ■ YoY decline in Specialty Po

  6. Slide 6: 2024 Outlook range narrowed

    2024 Outlook range narrowed Comments ● Not expecting broader recovery in H2 demand to support high end of prior outlook range EBITDA[3] €1.4 - 1.475 bn ● €50-100 million net pricing reduction ● Dissynergies (~€30 million) in 2024 related to separation ● R&I and IT investments, cost saving initiative

  7. Slide 7: Strengthening relationships in Asia

    Strengthening relationships in Asia Memorandum Partnership renewal with Joint lab with NIO of Understanding Ewha Womans University with Allozymes in South Korea to explore material innovation for sustainable automotive to leverage the power of to conduct cooperative applications enzymes to deliver c

  8. Slide 8: Azerys

    Acquisition controlling stake in natural rosemary extraction Azerys A specialist in rosemary extraction Produces 100% natural plant-based, non GMO preservatives range based on rosemary extract Which are able to replace chemical food additives End markets are Food & Beverages 8

  9. Slide 9: Recent announcements

    Recent announcements Launch Membership Partnership with Collaboration ECHO circular of Cerafy™ renewal of Agtech agreement with portfolio Hydrogen Council Innovation Orbex performance a range of biomimetic playing a leading joining forces to driving progress in launch of circular natural ceramides r

  10. Slide 10: The Syensqo Fund and Syensqo.ai

    THE SYENSQO FUND SYENSQO.AI Supporting philanthropic Launch of syensqo.ai and initiatives aimed SyGPT, a secure internal at improving conditions Chatbot to enhance for people and the planet employee productivity 10

  11. Slide 11: Scientific Advisory Board

    SCIENTIFIC ADVISORY BOARD: 4 leading academics supporting Syensqo growth innovation strategy From left to right: Ben Feringa, 2016 Nobel Prize winner and Professor of Chemistry at the University of Groningen, also former recipient of the 2015 Ernest Solvay Prize Karim Zaghib, Professor of Chemical a

  12. Slide 12: To the future of space exploration

    To the future of space exploration

  13. Slide 13: Celebrating the power of difference

    Ambra Sabatini 100 meters T63 category Paris, September 7 Celebrating the Trenten Merrill Long jump T64 category power of Paris, September 4 difference Kgothatso Montjane Wheelchair tennis Paris, August 30-September 7

  14. Slide 14: \\ EW

    \\ EW

Syensqo — Q2 2024 Earnings Presentation on 6ix